FDA Inspection 1269826 — Vitalant
The FDA completed an inspection of Vitalant on Apr 29, 2025 in Fargo, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 29, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fargo, ND (United States)